Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acorn Cardiovascular
Positive trial results reported on cardiac support device
December 7th, 2004
Acorn Cardiovascular announced that data presented at the Late Breaking Clinical Trials Session of the American Heart Association (AHA) 2004 Scientific Sessions indicates that the company's CorCap Cardiac Support Device (CSD) reversed heart failure progression and improved patient quality of life. The CorCap CSD is the first medical device specifically designed to address the problem of enlargement of the heart, a major contributing factor to heart failure progression. Results from the Acorn Clinical Trial of the CorCap CSD were presented by principal investigator, Douglas Mann of the Michael E. DeBakey VA Medical Center and Baylor College of Medicine. ...
Source: Cardiovascular Business Week (2004-12-07)
|
